Established in 1949, Shanghai Institute of Biological Products is a large state-owned enterprise integrating research, development, production and management of biological products, serving human health and improving national physique. It is a national master's degree awarding unit in biochemistry, molecular biology and pathogenic biology, and a high-tech biotechnology enterprise with accumulated talents at home and abroad.
Brief introduction of Wuhan Institute of Biological Products;
Wuhan Institute of Biological Products Co., Ltd. was incorporated in Jiangxia District Market Supervision Administration of Wuhan on March 8, 1990. The legal representative is Zeng, whose business scope covers the manufacture and sale of biological products and blood products; Manage the export business of self-produced products and related technologies of this enterprise.
On July 20 18, it was reported that 400520 DTP vaccine produced by Wuhan Institute of Biological Products was sold to Chongqing CDC 190520 and Hebei CDC 2 10000. On July 23, the US Food and Drug Administration in Wuhan has imposed an administrative penalty on Wuhan Institute of Biological Products Co., Ltd. involved in the DTP vaccine incident. On July 3 1 day, the State Medical and Drug Administration introduced that the unqualified vaccine of Wuhan BioDTP was accidental.
Refer to the above? Baidu Baike-Shanghai Institute of Biological Products